Ls Investment Advisors, LLC Vanda Pharmaceuticals Inc. Transaction History

Ls Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$9.32 - $12.02 $16,310 - $21,035	-1,750 Closed	0 $0
Q4 2019 Jan 31, 2020	SELL	$12.38 - $17.47 $25,205 - $35,568	-2,036 Reduced 53.78%	1,750 $29,000
Q1 2019 Apr 25, 2019	BUY	$17.59 - $31.05 $2,181 - $3,850	124 Added 3.39%	3,786 $70,000
Q4 2018 Feb 01, 2019	BUY	$18.97 - $31.47 $36,270 - $60,170	1,912 Added 109.26%	3,662 $96,000
Q3 2018 Nov 13, 2018	BUY	$18.25 - $23.0 $31,937 - $40,250	1,750 New	1,750 $40,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $294M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.